Literature DB >> 15880369

Blood component collection by apheresis.

Edwin A Burgstaler1.   

Abstract

Apheresis component collection is a rapidly growing area in the blood collection field. Several instruments with varying capabilities are available. This is a brief review of the equipment available for granulocyte and apheresis component collection and indications for their use. In the United States, granulocytes are collected with the Fenwal CS3000, Fenwal CS3000 Plus, COBE (Gambro) Spectra, Haemonetics LN9000, and Fresenius AS 104. The use of hetastarch for sedimenting agent and stimulation with G-CSF and G-CSF plus dexamethasone have substantially increased granulocyte yields. Plateletapheresis is performed in the United States on the Fenwal CS3000, Fenwal CS3000 Plus, Fenwal Amicus, COBE (Gambro) Spectra, Gambro Trima Version 4, Gambro Trima Accel (Version 5), and Haemonetics LN9000. Automated red blood cell (RBC) collections are performed with the Haemonetics MCS+LN8150, Gambro Trima Version 4, Gambro Trima Accel (Version 5), Amicus, and Baxter Alyx. The RBC can be collected concurrently (with other components) in some instruments or separately in others. Plasma is collected concurrently on several instruments. Plasmapheresis for plasma only is performed on the Fenwal Autopheresis C and Haemonetics PCS2. Granulocyte yields range from 0.46 x 10(10) to 1.0 x 10(10) for unstimulated donors and 2.1 x 10(10) to 2.6 x 10(10) for donors stimulated with dexamethasone or prednisone. The use of G-CSF and G-CSF with dexamethasone has substantially increased granulocyte yields with yields of 4.1 x 10(10) to 10.8 x 10(10) reported. Platelet collection rates of 0.045-0.115 x 10(11) plt/min have been reported. Collection efficiencies of 46-85.7% have been reported. Automated (apheresis) component collection has the advantages of controlled volumes or doses of component, efficient use of the donor, multiple components from the same donor, better inventory control, and better quality control due to less manipulation of the individual components. Disadvantages of automated component collection include the use of expensive equipment and disposables, the need for specially trained machine operators, and lower capacity to collect large volumes of blood compared to whole blood donation. The use of apheresis component collection is rapidly growing to provide the best blood components in the most efficient manner.

Entities:  

Mesh:

Year:  2006        PMID: 15880369     DOI: 10.1002/jca.20043

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  13 in total

1.  Analysis of Donor Safety in High Yield Plateletpheresis Procedures: An Experience from Tertiary Care Hospital in South India.

Authors:  Vijay Kumawat; Manu Goyal; Palniappan Marimuthu
Journal:  Indian J Hematol Blood Transfus       Date:  2020-02-27       Impact factor: 0.900

2.  Immature Platelet Count Levels as a Novel Quality Marker in Plateletpheresis.

Authors:  Ozlem Unay Demirel; Seyda Ignak; Mustafa Cagatay Buyukuysal
Journal:  Indian J Hematol Blood Transfus       Date:  2018-05-14       Impact factor: 0.900

3.  Donor Hemovigilance during Preparatory Plasmapheresis.

Authors:  Ulrich Diekamp; Johannes Gneißl; Angela Rabe; Stephan T Kießig
Journal:  Transfus Med Hemother       Date:  2014-02-17       Impact factor: 3.747

4.  Aggregates in blood filter chambers used from the plasma donations of anti-D donors: evaluation for monoclonal antibody discovery using phage display.

Authors:  Eunike C McGowan; Robert L Flower; Martina L Jones; David O Irving; Ross T Barnard; Catherine A Hyland; Stephen M Mahler; Xuan T Bui
Journal:  Blood Transfus       Date:  2020-10-09       Impact factor: 3.443

5.  Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS).

Authors:  Sherrill J Slichter; Jill Corson; Mary Kay Jones; Todd Christoffel; Esther Pellham; S Lawrence Bailey; Doug Bolgiano
Journal:  Blood       Date:  2013-11-20       Impact factor: 22.113

Review 6.  Successful autologous peripheral blood stem cell transplantation in a Jehovah's Witness with multiple myeloma: review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood products.

Authors:  S Schmitt; V Mailaender; G Egerer; A Leo; S Becker; P Reinhardt; M Wiesneth; H Schrezenmeier; A D Ho; H Goldschmidt; T M Moehler
Journal:  Int J Hematol       Date:  2008-03-04       Impact factor: 2.490

Review 7.  Citrate anticoagulation: Are blood donors donating bone?

Authors:  Walter Bialkowski; Roberta Bruhn; Gustaf Edgren; Paula Papanek
Journal:  J Clin Apher       Date:  2015-11-26       Impact factor: 2.821

8.  Mass-tag barcoding for multiplexed analysis of human synaptosomes and other anuclear events.

Authors:  Chandresh R Gajera; Rosemary Fernandez; Kathleen S Montine; Edward J Fox; Dunja Mrdjen; Nadia O Postupna; Christopher Dirk Keene; Sean C Bendall; Thomas J Montine
Journal:  Cytometry A       Date:  2021-04-05       Impact factor: 4.714

9.  Recovery of platelet-rich red blood cells and acquisition of convalescent plasma with a novel gravity-driven blood separation device.

Authors:  Dion Osemwengie; Johan W Lagerberg; Richard Vlaar; Erik Gouwerok; Mya Go; Arno P Nierich; Dirk de Korte
Journal:  Transfus Med       Date:  2021-11-10       Impact factor: 2.057

10.  Impact of frequent apheresis blood donation on bone density: A prospective, longitudinal, randomized, controlled trial.

Authors:  Walter Bialkowski; Robert D Blank; Cheng Zheng; Jerome L Gottschall; Paula E Papanek
Journal:  Bone Rep       Date:  2018-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.